Mentorship

Robert Altman, MBA ’88, has had a long career in executive roles for both mature and emerging biotech and pharmaceutical businesses. Most recently, Altman served as president of Pinnacle Biologics, a subsidiary of Concordia Healthcare. Altman also previously founded and built a fully-integrated specialty pharmaceutical company, Marathon Pharmaceuticals, and led the company as CEO and president from 2008 to 2012. Altman’s earlier career included numerous leadership positions over 17 years at Abbott Laboratories.

Mus Chagal is the former CEO of UICO, a venture-backed company with proprietary technology that enables touchscreens to work under direct exposure to water and liquids, and through gloves. He previously served as the chairman of the board of directors at UICO. Chagal has been involved in international trade acting as a bridge between American companies and suppliers from Turkey and Israel since 2002. He founded CWW/ Kudox NA, a private label manufacturer and supplier of radiant heat and building products and materials to retailers like Home and wholesalers like Wolseley-Ferguson. Chagal started his entrepreneurial career at FastWeb, a technology startup, as the senior vice president of sales and business development. FastWeb became the destination site and search engine for college bound students looking for scholarship, and the prominent one-to-one marketing and customer acquisition platform for companies targeting the youth market.

Joshua P. Fairbank has spent over two decades on both sides of the table; as an investor and as an entrepreneur. He is the president of Orchard Capital Management where he sits on the investment committees for the small cap value and the alternative asset strategies. In 2004 he co-founded and led the investment team at Orchard Ventures, a biotech VC fund. In addition to Orchard Capital and Orchard Ventures he is the cofounder of several companies. At Akebia (NASDAQ:AKBA) he wrote the original business plan, negotiated the spin-out from Procter & Gamble, and served as a founding director. Akebia is developing an anemia drug that mimics the body’s physiological response to high altitude, it has been tested in thousands of patients and is currently in late stage clinical trials. He runs Nymirum as its cofounder and executive chairman. Nymirum is a computational genetics firm that harnesses AI and big data to work on multiple unsolved diseases including cancers, neurodegenerative diseases, and infectious diseases. Fairbank has negotiated successful drug discovery partnerships with several leading global pharmaceutical companies and worked to obtain significant non-dilutive funding. He is a joint inventor on one of the company’s biophysics patents.

Fairbank will be taking meetings with faculty, scientists, healthcare startups, and students, once per month.

Melissa Harris, MBA ’16, is founder and CEO of M. Harris & Co., a Chicago-based marketing consultancy. She is a Pulitzer Prize-nominated business columnist and accomplished journalist who spent 15+ years at the Chicago Tribune, the Baltimore Sun, and the Orlando Sentinel. Prior to launching her company, she served as vice president of marketing at Origin Investments, a real estate private equity firm with about a half-billion dollars in assets. She has been named among the 50 most influential people in Chicago tech on Twitter by both Built In Chicago and Chicago Inno. She and her colleague won a Clio Award for her work on Cards Against Humanity Saves America.

Alex Hodgkin, MBA ’14, has spent the bulk of his career in investment banking and entrepreneurship. He has worked at Salomon Smith Barney and Headwaters MB. He is the cofounder and CEO of Intrinsic, a financial services firm providing valuation opinions and transaction advisory services to venture- and private equity-backed companies and high net worth individuals. Hodgkin has been instrumental in creating the entrepreneurship through acquisition program and community at the University of Chicago.

Doug Monieson, MBA ’89, is chairman emeritus of Hyde Park Angels (HPA), one of the largest and most active angel groups in the Midwest. He is currently executive chairman of the board of UICO, a rugged touch screen company founded at Chicago Booth and one of the first investments made by HPA. Monieson is also on the board of directors of Fishidy, a fishing app that was recently acquired by Ray Marine, a division of Flir. He also led the successful exit of Gradebeam, a SAAS business for the construction industry, which was purchased by Textura (TXTR) in 2011.

Ellen Rudnick, MBA ’73, is a successful startup executive, having served as chairman of Pacific Biometrics and CEO of Health Care Knowledge Resources. She has held positions as corporate vice president at Baxter Healthcare and president of Baxter Management Services Division, which she founded. Her current board experience includes Liberty Mutual Insurance, Patterson Companies (NASDAQ: PDCO), Health Management Systems (NASDAQ: HMSY), and First Midwest Bancorp (NASDAQ: FMBI). She was previously a venture partner for Inroads Capital. She was formerly the inaugural executive director of the Polsky Center.

Mark Tebbe is the founder of several startups, including two NASDAQ-listed companies: Lante and Answers Corp. In addition to serving as an EIR at the Polsky Center and an adjunct professor of entrepreneurship, he is an operating executive at Lake Capital and involved in the Chicago entrepreneurial and tech ecosystem.